Page last updated: 2024-08-21

isoxazoles and Connective Tissue Diseases

isoxazoles has been researched along with Connective Tissue Diseases in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Coghlan, JG; Denton, CP; Handler, CE; Kabunga, P; Smith, CJ; Valerio, CJ1
Barst, RJ; Frost, AE; Girgis, RE; Hill, NS; Horn, EM; Langleben, D; McLaughlin, VV; Oudiz, RJ; Robbins, IM; Seibold, JR; Shapiro, S; Tapson, VF1

Trials

1 trial(s) available for isoxazoles and Connective Tissue Diseases

ArticleYear
Selective endothelin A receptor antagonism with sitaxsentan for pulmonary arterial hypertension associated with connective tissue disease.
    Annals of the rheumatic diseases, 2007, Volume: 66, Issue:11

    Topics: Adolescent; Adult; Aged; Antihypertensive Agents; Blood Pressure; Cardiac Output; Connective Tissue Diseases; Dose-Response Relationship, Drug; Double-Blind Method; Endothelin A Receptor Antagonists; Female; Follow-Up Studies; Humans; Hypertension, Pulmonary; Isoxazoles; Male; Middle Aged; Quality of Life; Thiophenes; Treatment Outcome; Vascular Resistance; Walking

2007

Other Studies

1 other study(ies) available for isoxazoles and Connective Tissue Diseases

ArticleYear
Clinical experience with bosentan and sitaxentan in connective tissue disease-associated pulmonary arterial hypertension.
    Rheumatology (Oxford, England), 2010, Volume: 49, Issue:11

    Topics: Aged; Antihypertensive Agents; Bosentan; Clinical Trials as Topic; Connective Tissue Diseases; Female; Humans; Hypertension, Pulmonary; Isoxazoles; Male; Middle Aged; Statistics as Topic; Sulfonamides; Thiophenes; Treatment Outcome

2010